Lördag 26 April | 03:02:43 Europe / Stockholm
Svenska | English

Sareum Holdings

Beskrivning

LandStorbritannien
Lista52
SektorHälsovård
IndustriLäkemedel & Handel
Filter arrow-icon
År arrow-icon
Typ arrow-icon
Språk arrow-icon
Rensa
Se endast PM som skrivits på följande språk
Se endast PM som skrivits från valt år
Se endast PM som skrivits på följande språk
2025-04-24 08:00:12 Exercise of Warrants 16,80 GBP | +5,00%
2025-03-27 08:00:15 Director’s Dealing 13,00 GBP | +8,33%
2025-03-25 08:00:02 Sareum Half-Year Report 11,25 GBP | -8,16%
2025-03-20 08:00:12 Notice of HY Results and Investor Presentation 12,50 GBP | +2,04%
2025-03-13 08:15:19 Institutional Equity Fundraise 14,00 GBP | -15,15%
2025-03-13 08:08:43 Sareum Acquires Licence for SRA737 14,00 GBP | -15,15%
2024-12-31 08:00:04 Update on SRA737 24,50 GBP | -9,26%
2024-12-19 17:07:55 Results of AGM 27,00 GBP | -1,82%
2024-12-19 08:00:06 AGM Statement 27,00 GBP | -1,82%
2024-12-18 08:00:07 Appointment of Joint Broker 27,50 GBP | +1,85%
2024-12-17 10:14:35 Holding(s) in Company 27,00 GBP | 0,00%
2024-12-16 08:00:04 Award of Share Options 27,00 GBP | +1,89%
2024-11-27 10:38:19 Notice of AGM, Annual Report and Accounts 28,00 GBP | 0,00%
2024-10-29 08:00:04 Final Results for the Year Ended 30 June 2024 23,50 GBP | -6,00%
2024-10-23 08:00:09 Notice of Final Results and Investor Presentation 24,00 GBP | -4,00%
2024-10-21 08:00:04 Further Subscription to raise £1,000,000 26,00 GBP | -3,70%
2024-10-11 08:00:05 Subscription to raise £2,364,000 27,00 GBP | -1,82%
2024-09-16 08:00:03 Patent Allowance in China 28,00 GBP | +5,66%
2024-09-02 08:00:09 US patent allowance 29,00 GBP | +3,57%
2024-07-10 08:00:09 Management Changes 33,25 GBP | +5,56%
2024-07-01 08:00:04 Positive Data from SDC-1801 Phase 1 Clinical Trial 45,00 GBP | +1,12%
2024-05-30 08:00:14 Appointment of Sole Broker 40,50 GBP | -1,22%
2024-05-07 15:10:05 Exercise of Warrants 25,00 GBP | +3,09%
2024-04-23 08:00:06 Final Issue of RiverFort Subscription Shares 33,50 GBP | +44,09%
2024-04-19 12:35:10 Issue of RiverFort Subscription Shares 23,75 GBP | -11,21%
2024-04-15 16:28:52 Issue of RiverFort Subscription Shares 16,00 GBP | +10,34%
2024-04-09 17:00:46 Issue of RiverFort Subscription Shares 13,75 GBP | -1,79%
2024-04-04 15:38:22 Completion of Equity Fundraise 10,50 GBP | +2,44%
2024-04-02 17:51:15 Result of WRAP Retail Offer 10,25 GBP | -0,49%
2024-04-02 08:00:13 Increase in size of WRAP Retail Offer 10,30 GBP | -4,19%
2024-03-28 08:02:00 WRAP Retail Offer 10,75 GBP | -25,86%
2024-03-28 08:01:00 Equity Fundraise 10,75 GBP | -25,86%
2024-03-28 08:00:14 Sareum Half-Year Report 10,75 GBP | -25,86%
2024-03-15 08:00:06 New Patent Allowance 21,50 GBP | -10,42%
2024-03-12 14:30:00 Notice of Interim Results and Trading Update 27,50 GBP | -21,43%
2024-02-15 08:00:02 Update on SDC-1801 Clinical Trial Progress 40,00 GBP | +6,67%
2024-01-02 08:00:05 Development and commercialisation licence SRA737 67,50 GBP | +13,45%
2023-12-14 16:35:33 Results of AGM 55,00 GBP | -8,33%
2023-12-14 08:00:15 Annual General Meeting Statement 55,00 GBP | -8,33%
2023-11-23 08:00:07 Drawdown of Equity Prepayment Facility 60,00 GBP | -4,00%
2023-11-21 08:00:13 Notice of AGM, Annual Report and Accounts 62,50 GBP | -3,85%
2023-11-09 08:00:11 Initiation of food effects study for SDC-1801 57,50 GBP | 0,00%
2023-11-08 16:03:54 Director Dealings 57,50 GBP | 0,00%
2023-11-03 08:05:45 Sareum enhances SDC-1801 patent protection 62,50 GBP | +8,70%
2023-11-02 15:48:18 Exercise of Share Options and Director Dealings 57,50 GBP | -8,00%
2023-10-09 08:00:10 Final Results for the Year Ended 30 June 2023 75,00 GBP | -6,25%
2023-10-03 08:00:05 Notice of Results and Investor Presentation 82,50 GBP | +3,12%
2023-09-06 08:00:06 Director's Dealing 82,50 GBP | +3,12%
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden